RxDoctor Payments DataLook up a doctor →

Michael Plundo, DO

Family Medicine · Greensburg, PANPI 1932366945

Payments from drug & device makers

$151,485in general payments, 2019–2025

Across 1,213 payments — averaging $124.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$81K
  • AstraZeneca$35K
  • Johnson & Johnson$24K
  • AbbVie$2K
  • Lilly USA, LLC$1K
  • Amgen$895
  • plus $7K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk199$80,758
AstraZeneca165$34,603
Johnson & Johnson92$24,466
AbbVie(2 entities)242$2,488
Lilly USA, LLC70$1,010
Amgen54$895
E.r. Squibb & Sons, L.L.C.45$539
Pfizer33$515
Valeritas, Inc.10$412
GSK21$365
Mannkind Corporation9$327
Biohaven Pharmaceutical Holding Company Ltd.13$306
Amarin Pharma, Inc.21$282
Novartis17$276
Exact Sciences16$275
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC15$269
Abbott10$268
Boehringer Ingelheim14$249
Merck15$236
Daiichi Sankyo Inc.12$235
Bayer13$230
Kowa Pharmaceuticals America, Inc.15$206
Xeris Pharmaceuticals, Inc.12$200
Aimmune Therapeutics, Inc.10$152
Otsuka America Pharmaceutical, Inc.6$120
Novocure Inc.1$118
Scilex Pharmaceuticals Inc.1$106
Portola Pharmaceuticals, LLC1$103
Corcept Therapeutics5$101
Comsort, Inc1$100
Zealand Pharma US, Inc.5$94
Astellas Pharma US Inc4$90
Biohaven Pharmaceuticals, Inc.5$84
Acadia Pharmaceuticals Inc5$78
Dexcom, Inc.5$76
Phathom Pharmaceuticals, Inc.4$71
Teva Pharmaceuticals USA, Inc.5$68
Biogen4$64
Paratek Pharmaceuticals, Inc.3$57
Sanofi-aventis U.S. LLC4$54
Eisai Inc.3$53
Verona Pharma, Inc.2$46
Madrigal Pharmaceuticals1$44
Boston Scientific2$43
Sanofi Pasteur Inc.3$42
Arbor Pharmaceuticals, Inc.3$37
Idorsia Pharmaceuticals US Inc2$37
Seqirus USA Inc2$34
Takeda Pharmaceuticals U.S.A., Inc.2$26
Genentech USA, Inc.1$24
Esperion Therapeutics, Inc.1$21
Sun Pharmaceutical Industries Inc.1$20
Cequr Corporation1$18
Sumitomo Pharma America, Inc.1$16
Lundbeck LLC1$15
Insulet Corporation1$15
Shield Therapeutics Inc1$14
Medicure Pharma Inc.1$14
Currax Pharmaceuticals LLC1$12
Theracosbio, LLC1$9

How this compares

$151,485 in reported general payments places this provider in the 95th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$81,610
Medicare patients
198
Services billed
1,272

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Greensburg

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →